The incidence and number of deaths from non-tuberculous mycobacterial (NTM) disease
have been steadily increasing globally. These lesser known “cousins” of Mycobacterium …

Mycobacterium abscessus complex (MABC) is one of the most clinically relevant species
among nontuberculous mycobacteria. MABC's prevalence has increased over the last two …

A 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus
infection was treated with a three-phage cocktail following bilateral lung transplantation …

The increasing drug resistance of bacteria to commonly used antibiotics creates the need to
search for and develop alternative forms of treatment. Phage therapy fits this trend perfectly …

Mycobacteria are a unique group of microorganisms. They are characterised by exceptional
adaptability and durability. They are capable of colonisation and survival even in very …

Background We aimed to address the knowledge gap that exists regarding the
epidemiological, demographic, and clinical characteristics of nontuberculous mycobacterial …

Following the Mass Mortality Events (MMEs) of the pen shell P. nobilis in Campania region
and Sicily, a survey of moribund P. nobilis specimens was also conducted in other Italian …

Tuberculosis (TB) drug discovery and development has undergone nothing short of a
revolution over the past 20 years. Successful public–private partnerships and sustained …

Non-tuberculous mycobacteria (NTM) are ubiquitous dwellers of environmental niches and
are an established cause of natural and nosocomial infections. The incidence of NTM …

Infections caused by nontuberculous mycobacteria (NTM) are increasing globally.
Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex are the most …